{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:10:49Z","timestamp":1790644249515,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571833"],"award-info":[{"award-number":["81571833"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nonalcoholic fatty liver disease (NAFLD) is a worldwide chronic liver disease. Few studies have investigated the association between NAFLD and Lipoprotein-associated phospholipase A<jats:sub>2<\/jats:sub> (Lp-PLA<jats:sub>2<\/jats:sub>), a unique enzyme correlated with oxidative stress. The aim of this study was to assess the relationship between Lp-PLA<jats:sub>2<\/jats:sub> and NAFLD in a Chinese community-based cohort. A total of 1587 adults aged \u226540 years were enrolled in the current study. Participants underwent a standardized evaluation. The serum Lp-PLA2 concentration was measured by ELISA and NAFLD was diagnosed by ultrasonography. Multivariable logistic regression was used to assess the association between Lp-PLA2 and NAFLD. Increased Lp-PLA2 levels were significantly associated with decreased NAFLD prevalence after adjusting for other potential confounders. The adjusted ORs of NAFLD in Q2, Q3 and Q4 compared with Q1 were 0.88 (0.64\u20131.21), 0.71 (0.51\u20130.98) and 0.67 (0.48\u20130.95), respectively (P\u2009&lt;\u20090.05). Furthermore, the adjusted ORs of moderate and heavy NAFLD in Q2, Q3 and Q4 compared to Q1 were 0.64 (0.41\u20131.01), 0.48 (0.29\u20130.80) and 0.47 (0.28\u20130.79), respectively (P\u2009&lt;\u20090.01). In conclusions, increased Lp-PLA2 levels were independently associated with decreased NAFLD prevalence.<\/jats:p>","DOI":"10.1038\/s41598-018-28494-8","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T14:10:39Z","timestamp":1530195039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association of Lipoprotein-Associated Phospholipase A2 with the Prevalence of Nonalcoholic Fatty Liver Disease: A Result from the APAC Study"],"prefix":"10.1038","volume":"8","author":[{"given":"Zhongni","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"key":"28494_CR1","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00125-008-1135-4","volume":"51","author":"G Targher","year":"2008","unstructured":"Targher, G., Marra, F. & Marchesini, G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon. Diabetologia 51, 1947\u20131953 (2008).","journal-title":"Diabetologia"},{"key":"28494_CR2","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/ncpgasthep0879","volume":"4","author":"C Nugent","year":"2007","unstructured":"Nugent, C. & Younossi, Z. M. Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 4, 432\u2013441 (2007).","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"28494_CR3","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005\u20132023 (2012).","journal-title":"Hepatology"},{"key":"28494_CR4","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/j.1440-1746.2007.04995.x","volume":"22","author":"S Chitturi","year":"2007","unstructured":"Chitturi, S. & Farrell, G. C. Fatty liver now, diabetes and heart attack later? The liver as a barometer of metabolic health. J Gastroenterol Hepatol 22, 967\u2013969 (2007).","journal-title":"J Gastroenterol Hepatol"},{"key":"28494_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09851-5","volume":"7","author":"R Wu","year":"2017","unstructured":"Wu, R. et al. Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification in a Northern Chinese Population: a Cross Sectional Study. Sci Rep 7, 9933 (2017).","journal-title":"Sci Rep"},{"key":"28494_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MEG.0000000000000254","volume":"27","author":"J Luo","year":"2015","unstructured":"Luo, J. et al. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease. Eur J Gastroenterol Hepatol 27, 193\u2013199 (2015).","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"28494_CR7","first-page":"3319717704554","volume":"6","author":"C Wang","year":"2017","unstructured":"Wang, C. & Fang, X. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China. Angiology 6, 3319717704554 (2017).","journal-title":"Angiology"},{"key":"28494_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/1358863X16671424","volume":"22","author":"PK Garg","year":"2017","unstructured":"Garg, P. K. et al. Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease in a multi-ethnic cohort: The Multi-Ethnic Study of Atherosclerosis. Vasc Med 22, 5\u201312 (2017).","journal-title":"Vasc Med"},{"key":"28494_CR9","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s12020-012-9677-0","volume":"42","author":"L Abenavoli","year":"2012","unstructured":"Abenavoli, L., Milic, N. & Capasso, F. Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin. Endocrine 42, 754\u2013755 (2012).","journal-title":"Endocrine"},{"key":"28494_CR10","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1172\/JCI82204","volume":"125","author":"S Satapati","year":"2015","unstructured":"Satapati, S. et al. Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. J Clin Invest 125, 4447\u20134462 (2015).","journal-title":"J Clin Invest"},{"key":"28494_CR11","doi-asserted-by":"publisher","first-page":"32315","DOI":"10.1074\/jbc.272.51.32315","volume":"272","author":"A Matsuzawa","year":"1997","unstructured":"Matsuzawa, A., Hattori, K., Aoki, J., Arai, H. & Inoue, K. Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II. J Biol Chem 272, 32315\u201332320 (1997).","journal-title":"J Biol Chem"},{"key":"28494_CR12","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1194\/jlr.R024190","volume":"53","author":"RS Rosenson","year":"2012","unstructured":"Rosenson, R. S. & Stafforini, D. M. Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2. J Lipid Res 53, 1767\u20131782 (2012).","journal-title":"J Lipid Res"},{"key":"28494_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/met.2011.0111","volume":"10","author":"Y Colak","year":"2012","unstructured":"Colak, Y. et al. Association of serum lipoprotein-associated phospholipase A2 level with nonalcoholic fatty liver disease. Metab Syndr Relat Disord 10, 103\u2013109 (2012).","journal-title":"Metab Syndr Relat Disord"},{"key":"28494_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3109\/09513590.2010.487612","volume":"27","author":"A Derbent","year":"2011","unstructured":"Derbent, A. et al. Serum platelet-activating factor acetylhydrolase activity: relationship with metabolic syndrome in women with history of gestational diabetes mellitus. Gynecol Endocrinol 27, 128\u2013133 (2011).","journal-title":"Gynecol Endocrinol"},{"key":"28494_CR15","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1074\/jbc.M708622200","volume":"283","author":"N Kono","year":"2008","unstructured":"Kono, N. et al. Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo. Journal of Biological Chemistry 283, 1628\u20131636 (2008).","journal-title":"Journal of Biological Chemistry"},{"key":"28494_CR16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3109\/10715762.2015.1133906","volume":"50","author":"JE Kaikkonen","year":"2016","unstructured":"Kaikkonen, J. E. et al. Longitudinal study of circulating oxidized LDL and HDL and fatty liver: the Cardiovascular Risk in Young Finns Study. Free Radic Res 50, 396\u2013404 (2016).","journal-title":"Free Radic Res"},{"key":"28494_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/hep.510300122","volume":"30","author":"SI Svetlov","year":"1999","unstructured":"Svetlov, S. I., Sturm, E., Olson, M. S. & Crawford, J. M. Hepatic regulation of platelet-activating factor acetylhydrolase and lecithin:cholesterol acyltransferase biliary and plasma output in rats exposed to bacterial lipopolysaccharide. Hepatology 30, 128\u2013136 (1999).","journal-title":"Hepatology"},{"key":"28494_CR18","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1007\/s10620-006-9728-6","volume":"52","author":"AD Grypioti","year":"2007","unstructured":"Grypioti, A. D., Kostopanagiotou, G. & Mykoniatis, M. Platelet-activating factor inactivator (rPAF-AH) enhances liver\u2019s recovery after paracetamol intoxication. Dig Dis Sci 52, 2580\u20132590 (2007).","journal-title":"Dig Dis Sci"},{"key":"28494_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1476-511X-10-170","volume":"10","author":"IT Silva","year":"2011","unstructured":"Silva, I. T., Mello, A. P. & Damasceno, N. R. Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A2 (Lp-PLA2): a review. Lipids Health Dis 10, 170 (2011).","journal-title":"Lipids Health Dis"},{"key":"28494_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/liv.12523","volume":"34","author":"Z Tariq","year":"2014","unstructured":"Tariq, Z., Green, C. J. & Hodson, L. Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH). Liver Int 34, 180\u2013190 (2014).","journal-title":"Liver Int"},{"key":"28494_CR21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1172\/JCI73957","volume":"125","author":"G Gentric","year":"2015","unstructured":"Gentric, G. et al. Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease. J Clin Invest 125, 981\u2013992 (2015).","journal-title":"J Clin Invest"},{"key":"28494_CR22","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1074\/jbc.M004074200","volume":"276","author":"BJ Van Lenten","year":"2001","unstructured":"Van Lenten, B. J., Wagner, A. C., Navab, M. & Fogelman, A. M. Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6. J Biol Chem 276, 1923\u20131929 (2001).","journal-title":"J Biol Chem"},{"key":"28494_CR23","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1021\/pr400050u","volume":"12","author":"A Garcia-Heredia","year":"2013","unstructured":"Garcia-Heredia, A. et al. Paraoxonase-1 deficiency is associated with severe liver steatosis in mice fed a high-fat high-cholesterol diet: a metabolomic approach. J Proteome Res 12, 1946\u20131955 (2013).","journal-title":"J Proteome Res"},{"key":"28494_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bbalip.2009.02.015","volume":"1791,","author":"CC Tellis","year":"2009","unstructured":"Tellis, C. C. & Tselepis, A. D. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma. Biochim Biophys Acta 1791,, 327\u2013338 (2009).","journal-title":"Biochim Biophys Acta"},{"key":"28494_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.immuni.2004.09.003","volume":"21","author":"V Angeli","year":"2004","unstructured":"Angeli, V. et al. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21, 561\u2013574 (2004).","journal-title":"Immunity"},{"key":"28494_CR26","doi-asserted-by":"publisher","first-page":"e97841","DOI":"10.1371\/journal.pone.0097841","volume":"9","author":"EJ Kim","year":"2014","unstructured":"Kim, E. J. et al. Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation. Plos One 9, e97841 (2014).","journal-title":"Plos One"},{"key":"28494_CR27","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki, N., Mikhailidis, D. P. & Mantzoros, C. S. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 65, 1109\u20131123 (2016).","journal-title":"Metabolism"},{"key":"28494_CR28","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.2174\/1381612820666140622200916","volume":"20","author":"CC Tellis","year":"2014","unstructured":"Tellis, C. C. & Tselepis, A. D. Pathophysiological role and clinical significance of lipoprotein-associated phospholipase A2 (Lp-PLA2) bound to LDL and HDL. Curr Pharm Des 20, 6256\u20136269 (2014).","journal-title":"Curr Pharm Des"},{"key":"28494_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep33073","volume":"6","author":"R Jiang","year":"2016","unstructured":"Jiang, R. et al. Higher Levels of Lipoprotein Associated Phospholipase A2 is associated with Increased Prevalence of Cognitive Impairment: the APAC Study. Sci Rep 6, 33073 (2016).","journal-title":"Sci Rep"},{"key":"28494_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1751-2980.2010.00476.x","volume":"12","author":"JG Fan","year":"2011","unstructured":"Fan, J. G. et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010, 18, 163\u2013166). J Dig Dis 12, 38\u201344 (2011).","journal-title":"J Dig Dis"},{"key":"28494_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1440-1746.2007.05002.x","volume":"22","author":"GC Farrell","year":"2007","unstructured":"Farrell, G. C., Chitturi, S., Lau, G. K. & Sollano, J. D. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 22, 775\u2013777 (2007).","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28494-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28494-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28494-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:03:07Z","timestamp":1671606187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28494-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["28494"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-28494-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,4]]},"assertion":[{"value":"11 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10127"}}